Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography.
Gadolinium has physical properties that are well suited for radiographic imaging. Digital subtraction angiography with a gadolinium chelate as contrast medium can provide images of suitable quality for diagnosis and intervention. The overall safety profile of gadolinium-based contrast media is excellent. In particular, these contrast media are well tolerated in patients with renal insufficiency when administered intraarterially in doses of less than 0.3-0.4 mmol per kilogram body weight, with a decreased incidence of contrast medium-induced nephropathy, as compared with similar volumes of iodinated contrast material. The currently available formulations of gadolinium chelates can be injected safely into every arterial and venous structure. However, substantial data are lacking on the intraarterial use of gadolinium in patients with renal insufficiency, particularly at doses that exceed those routinely used in magnetic resonance angiography. Gadolinium chelates in appropriate volumes are useful alternative contrast media in selected high-risk patients undergoing angiographic studies.
Spinosa
David J
DJ
Department of Radiology, University of Virginia Health System, Charlottesville, VA 22908, USA. djs4m@virginia.edu
Kaufmann
John A
JA
Hartwell
Gary D
GD
D000792:Angiography; D002614:Chelating Agents / Q000009:adverse effects / Q000737:chemistry; D003287:Contrast Media; D004342:Drug Hypersensitivity; D019786:Gadolinium DTPA / Q000009:adverse effects / Q000737:chemistry; D006801:Humans; D007269:Injections, Intra-Arterial; D007674:Kidney Diseases / Q000139:chemically induced / Q000150:complications; D015642:Radiology, Interventional; D014283:Triiodobenzoic Acids / Q000009:adverse effects
D002614:Chelating Agents; D003287:Contrast Media; D014283:Triiodobenzoic Acids; D019786:Gadolinium DTPA